Clinical Trial Update: Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of radiofrequency ablation with cytokine-induced killer cells for cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Cytokine-induced killer cells
• Radiofrequency ablation (radiofrequency energy)

Snippet

Sponsor: The First People's Hospital of Changzhou | Conditions: Cervical Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING